Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alexa Kimball MD, MPH

Alexa Boer Kimball MD, MPH

President and CEO, Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, Inc.; Professor of Dermatology, Harvard Medical School, Boston, Massachusetts

Dr. Kimball is CEO and President of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, a $830 million academic multi-specialty 501(c)3 corporation with over 2200 employees, recognized by the Boston Globe as a top 10 Woman Led Business in Massachusetts. The group employs 2200 physicians and providers who practice in the Boston area, two-thirds of whom are Harvard Medical School faculty. She co-chairs the Beth Israel Lahey Health Performance Network Board (1.3 million members ) and is on the Board of Trustees of Beth Israel Lahey Health. A Professor of Dermatology at Harvard Medical School, Dr. Kimball’s research focus is psoriasis and hidradenitis suppurativa. She has published over 350 papers (, conducted over 150 clinical trials and has extensive experience in drug development and innovation, including two patents and several licensing agreements. Dr. Kimball is the author of "100 Questions and Answers about Psoriasis" (available in Spanish, Greek, and Korean), "Hidradenitis Suppurativa: Your Questions, Expert Answers," and editor of "Dermatologic Diseases and Cumulative Life Course Impairment." Awards include the American Skin Association Research Award for Health Policy and Medical Education, Mentor of the Year from the Women's Dermatologic Society, Outstanding Physician-Clinician Award from the National Psoriasis Foundation, Fierce HealthCare's Women of Influence Award, 2020, Lifetime Achievement Award from the National Psoriasis Foundation, the Joseph B. Martin Dean's Leadership Award for the Advancement of Women Faculty at Harvard Medical School, and Extraordinary Women Advancing Healthcare in Massachusetts by the Women's Edge. Dr. Kimball also serves on the Advisory Council to the Director of the National Institutes of Health (previously Francis Collins, MD, PhD). She has served on the Boards of the Society for Investigative Dermatology, the Massachusetts Foundation for the Humanities and Public Policy, the Hidradenitis Suppurativa Foundation, and the International Psoriasis Council. She received her MD from the Yale School of Medicine, her MPH from the Johns Hopkins Bloomberg School of Public Health, and a bachelor's degree in molecular biology and public and international affairs from Princeton University. She completed an internship in medicine at the Beth Israel Hospital, her residency in dermatology at Stanford University Medical Center and a clinical research fellowship at the National Institutes of Health.


Dr. Kimball serves/has served on several Organization of Teratology Information Specialists (OTIS) Advisory Board pregnancy registries, is a consultant and investigator for Abbvie, Janssen, Lilly, BMS, Moonlake, UCB and Amgen, has fellowship funding from Janssen and serves on the board of Almirall.